NBCC India Buy Recommendation: NBCC India Trading Now: 120-125 SUPPORT: 105 TARGET: 180 VIEW: SWING TO SHORT TERM If you have been watching the Indian (CLICK HERE)….
Read moreAuthor: positionalcalls.com
As the founder of PositionalCalls.com, Shubham Chaudhary is a seasoned technical analyst dedicated to empowering traders with strategic market insights. With a keen eye for chart patterns and a deep understanding of market dynamics, he translates complex data into actionable positional calls, helping clients navigate the stock market with confidence.
Gujarat Kidney & Super Speciality IPO: Should You Apply?
Gujarat Kidney & Super Speciality IPO: Gujarat Kidney & Super Speciality IPO is a ₹250.8 crore, fully fresh issue in the mid-size hospital and healthcare (CLICK HERE)….
Read more
Nephrocare Health IPO GMP Today: Listing Gain Forecast
Nephrocare Health IPO: Nephrocare Health IPO is emerging as one of December 2025’s most watched healthcare issues, combining India’s rapidly growing dialysis demand with a (CLICK HERE)….
Read more
Park Medi World IPO GMP, Review & Listing Gain Guide
Park Medi World IPO Main point: The Park Medi World IPO offers a promising healthcare opportunity with good profit potential and a plan to reduce (CLICK HERE)….
Read more
Corona Remedies IPO GMP Today: ₹300+ Gain?
Corona Remedies IPO 2025: Snapshot Corona Remedies Ltd is a Gujarat-based pharmaceutical company focused on branded formulations, chronic therapies, and prescription-driven products in India. The (CLICK HERE)….
Read more
Zuari Agro Chemicals Buy Recommendation 2025: ₹660 Target & Strategy
ZUARI AGRO CHEMICALS IS NOW TRADING NEAR 290 SUPPORT 170 TARGETS 650++ Zuari Agro Chemicals: Introduction: Why Is Trending Now The Indian fertilizer sector is (CLICK HERE)….
Read more
Meesho IPO 2025: Complete Investment Guide for Maximum Returns in India’s Value-Commerce Boom
Meesho IPO 2025: The financial markets are buzzing with anticipation as SoftBank-backed Meesho opens its doors to public investors on December 3-5, 2025. This isn’t (CLICK HERE)….
Read more
Aequs IPO 2025: Detailed Review, GMP, Valuation & Listing Strategy
Aequs IPO 2025: Main takeaway: The Aequs IPO is a ₹921.81 crore main-board issue in The Aequs IPO, which is part of the aerospace and (CLICK HERE)….
Read more
Vidya Wires IPO Review 2025: GMP, Price Band, Financials & Should You Invest?
Vidya Wires IPO Review 2025: The Vidya Wires IPO opens for subscription on December 3, 2025, offering investors an opportunity to participate in India’s booming (CLICK HERE)….
Read more
Tenneco Clean Air IPO 2025: Investment Guide, GMP Insights, and Listing Strategy
Tenneco Clean Air IPO 2025: Introduction: Why the Tenneco Clean Air IPO Is a Trending Topic With India’s car industry growing due to new regulations (CLICK HERE)….
Read more- NBCC India Buy Recommendation: Is This the Best Debt-Free PSU Stock for Your 2026 Portfolio?
- Gujarat Kidney & Super Speciality IPO: Should You Apply?
- Nephrocare Health IPO GMP Today: Listing Gain Forecast
- Park Medi World IPO GMP, Review & Listing Gain Guide
- Corona Remedies IPO GMP Today: ₹300+ Gain?
